These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 38129308
1. [Research advances on the role of Schwann cells in diabetic peripheral neuropathy]. Hao T, Cao T, Ji P, Zhang WF, Tao K. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Dec 20; 39(12):1190-1194. PubMed ID: 38129308 [Abstract] [Full Text] [Related]
6. Taurine protects against myelin damage of sciatic nerve in diabetic peripheral neuropathy rats by controlling apoptosis of schwann cells via NGF/Akt/GSK3β pathway. Li K, Shi X, Luo M, Inam-U-Llah, Wu P, Zhang M, Zhang C, Li Q, Wang Y, Piao F. Exp Cell Res; 2019 Oct 15; 383(2):111557. PubMed ID: 31415759 [Abstract] [Full Text] [Related]
7. Insulin-induced upregulation of lipoprotein lipase in Schwann cells during diabetic peripheral neuropathy. Rachana KS, Manu MS, Advirao GM. Diabetes Metab Syndr; 2018 Jul 15; 12(4):525-530. PubMed ID: 29602762 [Abstract] [Full Text] [Related]
11. Role of the Schwann cell in diabetic neuropathy. Eckersley L. Int Rev Neurobiol; 2002 Jul 15; 50():293-321. PubMed ID: 12198814 [Abstract] [Full Text] [Related]
12. Unveiling the Role of Schwann Cell Plasticity in the Pathogenesis of Diabetic Peripheral Neuropathy. Abd Razak NH, Idris J, Hassan NH, Zaini F, Muhamad N, Daud MF. Int J Mol Sci; 2024 Oct 08; 25(19):. PubMed ID: 39409114 [Abstract] [Full Text] [Related]
13. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Zhu J, Hu Z, Luo Y, Liu Y, Luo W, Du X, Luo Z, Hu J, Peng S. Front Endocrinol (Lausanne); 2023 Oct 08; 14():1265372. PubMed ID: 38264279 [Abstract] [Full Text] [Related]
15. Trehalose prevents sciatic nerve damage to and apoptosis of Schwann cells of streptozotocin-induced diabetic C57BL/6J mice. Pan H, Ding Y, Yan N, Nie Y, Li M, Tong L. Biomed Pharmacother; 2018 Sep 08; 105():907-914. PubMed ID: 30021384 [Abstract] [Full Text] [Related]
16. Deriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy. Majd H, Amin S, Ghazizadeh Z, Cesiulis A, Arroyo E, Lankford K, Majd A, Farahvashi S, Chemel AK, Okoye M, Scantlen MD, Tchieu J, Calder EL, Le Rouzic V, Shibata B, Arab A, Goodarzi H, Pasternak G, Kocsis JD, Chen S, Studer L, Fattahi F. Cell Stem Cell; 2023 May 04; 30(5):632-647.e10. PubMed ID: 37146583 [Abstract] [Full Text] [Related]
18. The Akt/mTOR cascade mediates high glucose-induced reductions in BDNF via DNMT1 in Schwann cells in diabetic peripheral neuropathy. Zhang CH, Lv X, Du W, Cheng MJ, Liu YP, Zhu L, Hao J. Exp Cell Res; 2019 Oct 01; 383(1):111502. PubMed ID: 31323191 [Abstract] [Full Text] [Related]
19. Schwann cell O-GlcNAcylation promotes peripheral nerve remyelination via attenuation of the AP-1 transcription factor JUN. Kim S, Maynard JC, Strickland A, Burlingame AL, Milbrandt J. Proc Natl Acad Sci U S A; 2018 Jul 31; 115(31):8019-8024. PubMed ID: 30012597 [Abstract] [Full Text] [Related]
20. STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy. Du W, Wang N, Li F, Jia K, An J, Liu Y, Wang Y, Zhu L, Zhao S, Hao J. FASEB J; 2019 Jul 31; 33(7):8008-8021. PubMed ID: 30913399 [Abstract] [Full Text] [Related] Page: [Next] [New Search]